A first-in-class CDK4 inhibitor demonstrates in vitro, ex-vivo and in vivo efficacy against ovarian cancer
首创的 CDK4 抑制剂在体外、离体和体内均显示出对抗卵巢癌的功效
期刊:Gynecologic Oncology
影响因子:4.5
doi:10.1016/j.ygyno.2020.09.012
Laychiluh Bantie, Solomon Tadesse, Jimma Likisa, Mingfeng Yu, Benjamin Noll, Gary Heinemann, Noor A Lokman, Carmela Ricciardelli, Martin K Oehler, Andrew Beck, Rupal Pradhan, Robert Milne, Hugo Albrecht, Shudong Wang